Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | -16.67% | -16.67% | -28.57% |
Sales 2024 * | 1.87M 2.83M | Sales 2025 * | 1.39M 2.11M | Capitalization | 17.24M 26.11M |
---|---|---|---|---|---|
Net income 2024 * | -8M -12.11M | Net income 2025 * | -10M -15.14M | EV / Sales 2024 * | 9.23 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.4 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.93% |
Latest transcript on Alterity Therapeutics Limited
1 day | -16.67% | ||
1 week | -16.67% | ||
Current month | -16.67% | ||
6 months | -28.57% | ||
Current year | -28.57% |
Managers | Title | Age | Since |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 17-04-30 |
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 14-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Peter Marks
BRD | Director/Board Member | 68 | 05-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 11-08-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.005 | -16.67% | 620 639 |
24-05-08 | 0.006 | 0.00% | 1,633,025 |
24-05-07 | 0.006 | 0.00% | 1,591,307 |
24-05-06 | 0.006 | +20.00% | 2,028,193 |
24-05-03 | 0.005 | -16.67% | 91,108,610 |
Delayed Quote Australian S.E., May 09, 2024 at 02:10 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.57% | 20.69M | |
+24.61% | 46.71B | |
+48.83% | 41.8B | |
-1.09% | 41.52B | |
-3.42% | 29.55B | |
+10.50% | 25.78B | |
-21.42% | 19.26B | |
+1.09% | 12.14B | |
-3.55% | 12.08B | |
+27.07% | 11.98B |
- Stock Market
- Equities
- ATH Stock